Article
Adenovirus p53 gene therapy
22 Dec 2005
Abstract excerpt
To date, dysfunctional tumour suppressor genes are the most common genetic lesions identified in human cancers. Functional copies of tumour suppressor genes can be introduced into cancer cells by gene transfer using adenoviral vectors. This approach has been extensively studied in the clinic with intratumoural injection of a replication-defective adenovirus that expresses p53 (Ad-p53). Overexpression of p53 in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
